Research innovations from HHM investigators
Members of the Hematopoiesis and Hematologic Malignancies research program at IU Simon Comprehensive Cancer Center are leading remarkable laboratory and clinical studies that reduce the burden of cancer.
Members of the Hematopoiesis and Hematologic Malignancies research program at IU Simon Comprehensive Cancer Center are leading remarkable laboratory and clinical studies that reduce the burden of cancer.
Ngoc Tung Tran, PhD, and colleagues published an article in the high-impact journal Science Advances for their work on gene editing in hematopoietic stem cells.
A faculty member of the Department of Pediatrics at IU School of Medicine, Dr. Tran is developing a research program to study hematopoietic malignancies. His ultimate goal is to develop gene therapy and therapeutic approaches for blood disorders.